AGIOS PHARMACEUTICALS, INC. Annual Costs and Expenses in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Agios Pharmaceuticals, Inc. quarterly/annual Costs and Expenses history and growth rate from 2017 to 2023.
  • Agios Pharmaceuticals, Inc. Costs and Expenses for the quarter ending September 30, 2024 was $112M, a 3.21% increase year-over-year.
  • Agios Pharmaceuticals, Inc. Costs and Expenses for the twelve months ending September 30, 2024 was $440M, a 7.7% increase year-over-year.
  • Agios Pharmaceuticals, Inc. annual Costs and Expenses for 2023 was $418M, a 3.73% increase from 2022.
  • Agios Pharmaceuticals, Inc. annual Costs and Expenses for 2022 was $403M, a 6.57% increase from 2021.
  • Agios Pharmaceuticals, Inc. annual Costs and Expenses for 2021 was $378M, a 12.7% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $418M +$15M +3.73% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-15
2022 $403M +$24.9M +6.57% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-15
2021 $378M +$42.5M +12.7% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-15
2020 $336M +$19.6M +6.21% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-23
2019 $316M -$141M -30.8% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 $457M +$93.1M +25.6% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 $364M Jan 1, 2017 Dec 31, 2017 10-K 2020-02-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.